Real-world practice of obstetricians in respect of assays for antiphospholipid antibodies

References

• Farquharson RG, Pearson JF, John L. Lupus anticoagulant and pregnancy management. Lancet. 1984;2(8396):228–9.
   PubMed Web of Science ®Google Scholar
• Sugiura-Ogasawara M, Ozaki Y, Sato T, Suzumori N, Suzumori K. Poor prognosis of recurrent aborters with either maternal or paternal reciprocal translocation. Fertil Steril. 2004;81(2):367–73.
   PubMed Web of Science ®Google Scholar
• Sugiura-Ogasawara M, Ozaki Y, Kitaori T, Kumagai K, Suzuki S. Midline uterine defect size correlated with miscarriage of euploid embryos in recurrent cases. Fertil Steril. 2010;93(6):1983–8.
   PubMed Web of Science ®Google Scholar
• Sugiura-Ogasawara M, Ozaki Y, Katano K, Suzumori N, Kitaori T, Mizutani E. Abnormal embryonic karyotype is the most frequent cause of recurrent miscarriage. Hum Reprod. 2012;27(8):2297–303.
   PubMed Web of Science ®Google Scholar
• Branch DW, Gibson M, Silver RM. Clinical Practice: Recurrent miscarriage. N Engl J Med. 2010;363:1740–7.
   PubMed Web of Science ®Google Scholar
• Cowchock FS, Reece EA, Balaban D, Branch DW, Plouffe L. Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment. Am J Obstet Gynecol. 1992;166(5): 1318–23.
   PubMed Web of Science ®Google Scholar
• Rai R, Cohen H, Dave M, Regan L. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ. 1997;314(7076):253–7.
   PubMed Web of Science ®Google Scholar
• Kutteh WH. Antiphospholipid antibody-associated recurrent pregnancy loss: Treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol. 1996;174(5): 1584–9.
   PubMed Web of Science ®Google Scholar
• Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement of an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4(2):295–306.
   PubMed Web of Science ®Google Scholar
• Pengo V, Tripod A, Reber G, Rand JH, Ortel TL, Galli M, De Groot PG. Update of the guidelines for lupus anticoagulant detection. J Thromb Haemost. 2009;7:1737–40.
   PubMed Web of Science ®Google Scholar
• Harris EN, Gharavi AE, Patel BM, Hughes GR. Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4 April 1986. Clin Exp Immunol. 1987;68(1):215–22.
   PubMed Web of Science ®Google Scholar
• Matsuura E, Igarashi Y, Yasuda T, Triplett DA, Koike T. Anticardiolipin antibodies recognize β2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. J Exp Med. 1994;179(2):457–62.
   PubMed Web of Science ®Google Scholar
• Sugi T, McIntyre JA. Autoantibodies to phosphatidylethanolamine (PE) recognize a kininogen-PE complex. Blood. 1995;86(8):3083–9.
   PubMed Web of Science ®Google Scholar
• Atsumi T, Ieko M, Bertolaccini ML, Ichikawa K, Tsutsumi A, Matsuura E, Koike T. Association of autoantibodies against the phosphatidylserine-prothrombin complex with manifestations of antiphospholipid syndrome and with the presence of lupus anticoagulant. Arthritis Rheum. 2000;43(9):1982–93.
   PubMed Web of Science ®Google Scholar
• Guidelines for obstetrical practice in Japan: Japan Society of Obstetrics and Gynecology (JSOG) and Japan Association of Obstetricians and Gynecologists (JAOG) 2014 edition. 2014: 119–24.
   Google Scholar
• Kaandorp SP, Goddijn M, van der Post JAM, Hutten BA, Verhoeve HR, Hamulyak K, et al. Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. N Engl J Med. 2010;362(17):1586–96.
   PubMed Web of Science ®Google Scholar
• Katano K, Suzuki S, Ozaki Y, Suzumori N, Kitaori T, Sugiura-Ogasawara M. Peripheral natural killer cell activity as a predictor of recurrent pregnancy loss: a large cohort study. Fertil Steril. 2013;100(6):1629–34.
   PubMed Web of Science ®Google Scholar
• Lockshin MD, Kim M, Laskin CA, Guerra M, Branch DW, Merrill J, et al. Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies. Arthritis Rheum. 2012;64(7):2311–8.
   PubMed Web of Science ®Google Scholar
• Harris EN, Spinnato JA. Should anticardiolipin tests be performed in otherwise healthy pregnant women? Am J Obstet Gynecol. 1991;165(5 Pt 1):1272–7.
   PubMed Web of Science ®Google Scholar
• Katano K, Aoki K, Sasa H, Ogasawara M, Matsuura E, Yagami Y.β2glycoproteinI-dependent anticardiolipin antibodies as a predictor of adverse pregnancy outcomes in healthy pregnant women. Hum Reprod. 1996;11:509–12.
   PubMed Web of Science ®Google Scholar
• Obayashi S, Ozaki Y, Sugi T, Kitaori T, Suzuki S, Sugiura-Ogasawara M. Antiphosphatidylethanolamine antibodies might not be independent risk factors for further miscarriage in patients suffering recurrent pregnancy loss. J Reprod Immunol. 2010;85(2):186–92.
   PubMed Web of Science ®Google Scholar
• Sugi T, Katsunuma J, Izumi S, McIntyre JA, Makino T. Prevalence and heterogeneity of antiphosphatidylethanolamine antibodies in patients with recurrent early pregnancy losses. Fertil Steril. 1999;71(6): 1060–5.
   PubMed Web of Science ®Google Scholar
• Preston FE, Rosendaal FR, Walker ID, Bri€t E, Berntorp E, Conard J, et al. Increased fetal loss in women with heritable thrombophilia. Lancet. 1996;348:913–16.
   PubMed Web of Science ®Google Scholar
• Kupferminc MJ, Eldor A, Steinman N, Many A, Bar-Am A, Jaffa A, et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med. 1999;340:50–2.
   PubMed Web of Science ®Google Scholar